Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer.
Wilson AJ, Fadare O, Beeghly-Fadiel A, Son DS, Liu Q, Zhao S, Saskowski J, Uddin MJ, Daniel C, Crews B, Lehmann BD, Pietenpol JA, Crispens MA, Marnett LJ, Khabele D.
Wilson AJ, et al. Among authors: zhao s.
Oncotarget. 2015 Aug 28;6(25):21353-68. doi: 10.18632/oncotarget.3860.
Oncotarget. 2015.
PMID: 25972361
Free PMC article.